PELLOSO, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 3.678
AS - Asia 2.385
EU - Europa 1.028
SA - Sud America 387
AF - Africa 331
Continente sconosciuto - Info sul continente non disponibili 63
OC - Oceania 28
Totale 7.900
Nazione #
US - Stati Uniti d'America 3.464
SG - Singapore 761
CN - Cina 547
VN - Vietnam 396
BR - Brasile 258
IT - Italia 200
HK - Hong Kong 181
FI - Finlandia 119
DE - Germania 95
PL - Polonia 92
FR - Francia 78
BD - Bangladesh 76
IN - India 66
SE - Svezia 59
GB - Regno Unito 58
RU - Federazione Russa 48
CA - Canada 40
IQ - Iraq 34
MX - Messico 29
UA - Ucraina 28
AR - Argentina 27
ID - Indonesia 27
NL - Olanda 26
EC - Ecuador 21
JP - Giappone 21
SA - Arabia Saudita 20
TR - Turchia 19
CL - Cile 16
PH - Filippine 16
PK - Pakistan 16
CO - Colombia 15
EG - Egitto 15
ES - Italia 15
IE - Irlanda 15
JM - Giamaica 15
MA - Marocco 15
PY - Paraguay 15
AT - Austria 14
BW - Botswana 14
LC - Santa Lucia 14
ZA - Sudafrica 14
AE - Emirati Arabi Uniti 13
BZ - Belize 13
LY - Libia 13
TN - Tunisia 13
CW - ???statistics.table.value.countryCode.CW??? 12
CZ - Repubblica Ceca 12
HR - Croazia 12
KR - Corea 12
BE - Belgio 11
DO - Repubblica Dominicana 11
GH - Ghana 11
GT - Guatemala 11
IR - Iran 11
NE - Niger 11
UZ - Uzbekistan 11
ZM - Zambia 11
AL - Albania 10
AZ - Azerbaigian 10
CI - Costa d'Avorio 10
GR - Grecia 10
KE - Kenya 10
MG - Madagascar 10
NP - Nepal 10
PR - Porto Rico 10
AU - Australia 9
BF - Burkina Faso 9
BJ - Benin 9
CR - Costa Rica 9
CY - Cipro 9
ET - Etiopia 9
GA - Gabon 9
IL - Israele 9
MD - Moldavia 9
MY - Malesia 9
MZ - Mozambico 9
TT - Trinidad e Tobago 9
TZ - Tanzania 9
VE - Venezuela 9
AO - Angola 8
BB - Barbados 8
BY - Bielorussia 8
CV - Capo Verde 8
DZ - Algeria 8
KZ - Kazakistan 8
ME - Montenegro 8
MK - Macedonia 8
MR - Mauritania 8
PE - Perù 8
PS - Palestinian Territory 8
SI - Slovenia 8
TH - Thailandia 8
TJ - Tagikistan 8
TW - Taiwan 8
YT - Mayotte 8
BO - Bolivia 7
CG - Congo 7
GN - Guinea 7
JO - Giordania 7
LA - Repubblica Popolare Democratica del Laos 7
Totale 7.556
Città #
Ashburn 513
Singapore 458
San Jose 361
Woodbridge 277
Fairfield 263
Chandler 234
Houston 180
Hong Kong 162
Ann Arbor 142
Cambridge 116
Ho Chi Minh City 115
Beijing 105
Seattle 100
Wilmington 98
Santa Clara 81
Hanoi 80
Bytom 74
Helsinki 70
Los Angeles 66
Boardman 58
Jacksonville 50
Dong Ket 49
Princeton 43
Medford 39
New York 39
Lauterbourg 38
Padova 34
Nanjing 33
Des Moines 31
São Paulo 31
Buffalo 30
Roxbury 28
Da Nang 24
Munich 24
San Diego 23
Shanghai 23
Atlanta 22
Milan 21
Guangzhou 19
Chicago 18
Shenyang 16
Dallas 15
Frankfurt am Main 15
Orem 15
Castries 14
Biên Hòa 13
Dublin 13
Gaborone 13
Jinan 13
Montreal 13
Warsaw 13
Baghdad 12
Kingston 12
Rome 12
Tokyo 12
Turku 12
Zhengzhou 12
Denver 11
Florence 11
London 11
Niamey 11
Redondo Beach 11
Tianjin 11
Chennai 10
Haiphong 10
Hefei 10
Lusaka 10
Nanchang 10
Tashkent 10
Cotonou 9
Dar es Salaam 9
Hải Dương 9
Johannesburg 9
Libreville 9
Ouagadougou 9
San Francisco 9
Toronto 9
Abidjan 8
Addis Ababa 8
Antananarivo 8
Baku 8
Bridgetown 8
Cairo 8
Kathmandu 8
Nouakchott 8
Praia 8
Pune 8
Santiago 8
Thái Nguyên 8
Willemstad 8
Zagreb 8
Accra 7
Amsterdam 7
Belize City 7
Brooklyn 7
Changsha 7
Conakry 7
Dakar 7
Jeddah 7
Lima 7
Totale 4.770
Nome #
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 338
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 332
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 314
Performance criteria and quality indicators for the post-analytical phase 292
Automated measurement of the erythrocyte sedimentation rate: Method validation and comparison 291
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 261
Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting 261
Ves-Matic CUBE 200: Is modified Westergren method for erythrocyte sedimentation rate a valid alternative to the gold standard? 256
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 226
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 224
Laboratory critical values: automated notification supports effective clinical decision making. 224
Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear 217
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 214
Pathogenesis of Helicobacter pylori in humans. 210
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 197
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 192
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 192
T Cell Senescence by Extensive Phenotyping: An Emerging Feature of COVID-19 Severity 190
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 190
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 182
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 182
PRE-ANALYTICAL EFFECTS ON ESTABLISHED AND EMERGING BIOMARKERS OF CARDIOVASCULAR DISEASE (CVD) 175
Validation of a composed COVID-19 chest radiography score: the CARE project 171
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 171
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 170
Performance specifications of critical results management 170
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 168
One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients 161
It's not just the lungs: COVID-19 and the misty mesentery sign 160
The CagL GLU59 Polymorphism of H. pylori is associated with an increasedrisk of gastric cancer. Preliminaryresults from an Italian multicenter study. 158
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 157
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 155
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 153
AUTOMATED IT-BASED INTERVAL POP-UP (POP-UP) HAS LITTLE IMPACT ON VITAMIN D (VITD) APPROPRIATE MINIMUM RETESTING 149
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 145
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 143
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 136
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 132
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 129
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 112
Totale 7.900
Categoria #
all - tutte 21.660
article - articoli 12.604
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 560
Totale 34.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022389 0 77 28 21 19 39 10 31 20 7 25 112
2022/2023471 81 50 5 76 68 52 5 31 62 11 24 6
2023/2024283 6 27 48 15 20 50 37 27 1 17 14 21
2024/20251.042 2 23 56 45 137 16 55 92 93 48 197 278
2025/20264.045 194 349 479 502 434 176 567 359 433 259 201 92
2026/2027145 143 2 0 0 0 0 0 0 0 0 0 0
Totale 7.900